Melinda Richter

Global Head of JLABS, Johnson & Johnson Innovation

“Improving access to medicines starts with shortening the amount of time it takes to get a therapeutic into the hands of the patient or consumer. Typically, that process can take up to ten years and millions or even billions of dollars. This has to change! I’ve worked tirelessly to streamline this process for healthcare entrepreneurs, via our Johnson & Johnson Innovation – JLABS model, and will continue to work to shorten that development cycle and to make it more affordable to ultimately get medicines into the hands of those who need them most.”

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019